CECR2

Across TCGA pan-cancer cohorts, CECR2 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated CECR2 data layer compared with 20 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CECR2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated CECR2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and GBM show a favorable association.

LUAD and GBM are the cancer types where CECR2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.925	0.351	.016	3	view →
GBM	OS	Tertile	All	0.669	0.342	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

CECR2–LUAD (OS)

Open the LUAD breakdown →